Seelos Therapeutics
SEEL
#10585
Rank
โ‚ฌ0.18 M
Marketcap
0,31ย โ‚ฌ
Share price
-31.49%
Change (1 day)
-98.31%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): โ‚ฌ4.2 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ32.15 Million, an increase over its 2022 earnings that were of -โ‚ฌ62.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ4.2 M-113.09%
2023 -โ‚ฌ32.15 Million-48.58%
2022 -โ‚ฌ62.51 Million14.07%
2021 -โ‚ฌ54.8 Million240.34%
2020 -โ‚ฌ16.11 Million-62.76%
2019 -โ‚ฌ43.24 Million587.73%
2018 -โ‚ฌ6.29 Million-36.54%
2017 -โ‚ฌ9.91 Million74.83%
2016 -โ‚ฌ5.67 Million-63.26%
2015 -โ‚ฌ15.43 Million-18.06%
2014 -โ‚ฌ18.83 Million46.19%
2013 -โ‚ฌ12.88 Million-31.67%
2012 -โ‚ฌ18.85 Million
2010 -โ‚ฌ17.66 Million448.63%
2009 -โ‚ฌ3.22 Million-25.83%
2008 -โ‚ฌ4.34 Million-45.65%
2007 -โ‚ฌ7.99 Million2.82%
2006 -โ‚ฌ7.77 Million-41.86%
2005 -โ‚ฌ13.35 Million-9.27%
2004 -โ‚ฌ14.72 Million114.92%
2003 -โ‚ฌ6.85 Million-70.78%
2002 -โ‚ฌ23.44 Million60.2%
2001 -โ‚ฌ14.63 Million70.3%
2000 -โ‚ฌ8.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA